Valerio Therapeutics Société anonyme (EPA:ALVIO)
France · Delayed Price · Currency is EUR 0.4735
+0.0005 (0.11%)
Nov 12, 2026, 9:24 AM CET
EPA:ALVIO Market Cap
EPA:ALVIO has a market cap or net worth of €236.49 million as of November 11, 2026. It is the 18,922nd most valuable company in the world and the 237th biggest in France. Its market cap has increased by 178.03% in one year.
Market Cap
236.49M
Enterprise Value
249.16M
Revenue
5.55M
Global Rank
Country Rank
#237 France
PE Ratio
n/a
ChartMarket Cap Chart
Since December 8, 2005, EPA:ALVIO's market cap has increased from 72.77M to 236.49M, an increase of 224.99%. That is a compound annual growth rate of 5.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2026 | 236.49M | 250.56% |
| Dec 31, 2025 | 67.46M | 484.18% |
| Dec 31, 2024 | 11.55M | -54.58% |
| Dec 29, 2023 | 25.42M | 62.58% |
| Dec 30, 2022 | 15.64M | -59.41% |
| Dec 31, 2021 | 38.52M | -25.93% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MedinCell | 1.08B |
| Inventiva | 786.81M |
| DBV Technologies | 615.84M |
| Genfit | 551.34M |
| Valneva SE | 492.38M |
| Transgene | 201.85M |
| Innate Pharma | 122.37M |
| Sensorion | 89.23M |